The association of lipoprotein(a) and apolipoprotein(a) phenotypes with peripheral artery disease

The association of lipoprotein(a) and apolipoprotein(a) phenotypes with peripheral artery disease

Aim. Lipoprotein(a) [Lp(a)] is an independent risk factor of coronary heart disease (CHD) and myocardial infarction. Data about the role of Lp(a) in the development of peripheral artery disease (PAD) is controversial and uncertain. The aim of the study was to evaluate the association between Lp(a),...

Full description

Bibliographic Details
Main Authors:	N A Tmoyan, M V Ezhov, O I Afanasieva, E A Klesareva, O A Razova, V V Kukharchuk, S N Pokrovsky
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2018-09-01
Series:	Терапевтический архив
Subjects:	lipoprotein(a) apolipoprotein(a) phenotypes atherosclerosis peripheral artery disease atherosclerosis of lower limbs arteries
Online Access:	https://ter-arkhiv.ru/0040-3660/article/viewFile/32986/pdf

Similar Items

Lipoprotein(a) and Cardiovascular Outcomes after Revascularization of Carotid and Lower Limbs Arteries
by: Marat V. Ezhov, et al.
Published: (2021-02-01)

RAISED LEVEL OF LIPOPROTEIDE(A) AS A PREDICTOR OF CARDIOVASCULAR COMPLICATION POST REVASCULARIZATION OF THE LOWER ExTREMETIES ARTERIES
by: N. A. Tmojan, et al.
Published: (2018-09-01)

Lipoprotein(a), its autoantibodies, and circulating T lymphocyte subpopulations as independent risk factors for coronary artery atherosclerosis
by: O I Afanasievа, et al.
Published: (2016-09-01)

INFLUENCE OF NICOTINIC ACID ON SUBFRACTIONAL SPECTRUM OF LOW, INTERMEDIATE AND HIGH DENSITY LIPOPROTEINS IN PATIENTS WITH HYPERLIPOPROTEINEMIA(а)
by: E. A. Utkina, et al.
Published: (2017-06-01)

Lipoprotein (a) polymorphism as a risk factor of coronary and carotid atherosclerosis and its complications in women
by: O. I. Afanasyeva, et al.
Published: (2010-12-01)

Efficacy and Safety of High-Density Lipoprotein/Apolipoprotein A1 Replacement Therapy in Humans and Mice With Atherosclerosis: A Systematic Review and Meta-Analysis
by: Ayiguli Abudukeremu, et al.
Published: (2021-08-01)

Lipoprotein(a), Immunity, and Inflammation in Polyvascular Atherosclerotic Disease
by: Narek A. Tmoyan, et al.
Published: (2021-01-01)

Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?
by: Michael B. Boffa, et al.
Published: (2016-05-01)

The heterogeneity of lipoproteins and their role in the development of cardiovascular diseases
by: E. A. Utkina, et al.
Published: (2019-06-01)

Serum Lipoprotein(a) Levels in Patients with Atherosclerotic Peripheral Vascular Disease in Hospital Kuala Lumpur
by: N.A. Hakim, et al.
Published: (2008-01-01)

Small size apolipoprotein(a) isoforms enhance inflammatory and proteolytic potential of collagen-primed monocytes
by: Nadia Sabbah, et al.
Published: (2019-08-01)

B9-17: A suitable construct for apolipoprotein B-containing lipoprotein assembly studies
by: Sepulveda Chervony, Melyorise
Published: (2016)

FACTORS INFLUENCING ON THE MORTALITY IN PATIENTS WITH OBLITERATING DISEASES OF LOWER LIMB ARTERIES
by: A. N. Sumin, et al.
Published: (2017-12-01)

Lipoprotein(a), homocysteine and coronary atherosclerosis in young and middle-aged men
by: M. V. Ezhov, et al.
Published: (2008-10-01)

CORRELATIONS OF LOW MOLECULAR WEIGHT PHENOTYPE OF APOPROTEIN(A) AND SERUM LEVEL OF LIPOPROTEIN(A) WITH MULTIFOCAL ATHEROSCLEROSIS IN PATIENTS WITH CORONARY HEART DISEASE
by: O. I. Afanasieva, et al.
Published: (2016-01-01)

RAISED IgM AUTOANTIBODY TITER TO LIPOPROTEIDE(A) AS ANTIATHEROGENIC FACTOR IN SEVERE HYPERCHOLESTEROLEMIA PATIENTS
by: E. A. Klesareva, et al.
Published: (2018-09-01)

A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids
by: Mohamad Navab, et al.
Published: (2009-08-01)

Emerging evidences for the opposite role of apolipoprotein C3 and apolipoprotein A5 in lipid metabolism and coronary artery disease
by: Wen Dai, et al.
Published: (2019-12-01)

Association of APOE genotype with carotid atherosclerosis in men and women
by: Roberto Elosua, et al.
Published: (2004-10-01)

High-level lipoprotein [a] expression in transgenic mice: evidence for oxidized phospholipids in lipoprotein [a] but not in low density lipoproteins
by: Matthias Schneider, et al.
Published: (2005-04-01)

Interrelation between neutrophil-lymphocyte ratio and chronic lower limb ischemia
by: O. M. Voloshyn
Published: (2018-06-01)

Combined Atherosclerotic Lesions in Patients with Type 2 Diabetes Mellitus
by: L.V. Khimion, et al.
Published: (2016-04-01)

The Apolipoprotein M–Sphingosine-1-Phosphate Axis: Biological Relevance in Lipoprotein Metabolism, Lipid Disorders and Atherosclerosis
by: Bas W. C. Arkensteijn, et al.
Published: (2013-02-01)

Scavenger receptor-BI is a receptor for lipoprotein(a)
by: Xiao-Ping Yang, et al.
Published: (2013-09-01)

Plasma apolipoprotein O level increased in the patients with acute coronary syndrome
by: Bi-lian Yu, et al.
Published: (2012-09-01)

Crossroads between peripheral atherosclerosis, western-type diet and skeletal muscle pathophysiology: emphasis on apolipoprotein E deficiency and peripheral arterial disease
by: Peggy Sfyri, et al.
Published: (2017-07-01)

Anti-inflammatory and cholesterol-reducing properties of apolipoprotein mimetics: a review
by: C. Roger White, et al.
Published: (2014-10-01)

Role of inflammation, autotaxin and lipoprotein (a) in degenerative aortic valve stenosis in patients with coronary artery disease
by: A. L. Burdeynaya, et al.
Published: (2021-03-01)

Overexpressed lipoprotein lipase protects against atherosclerosis in apolipoprotein E knockout mice
by: Hiroaki Yagyu, et al.
Published: (1999-09-01)

Structural basis for the pathophysiology of lipoprotein(a) in the athero-thrombotic process
by: E. Anglés-Cano
Published: (1997-11-01)

SPECIFICS OF SUBFRACTIONAL SPECTRUM OF APOLIPOPROTEIN B RELATED LIPOPROTEINES IN CAROTID OR CORONARY ATHEROSCLEROSIS PATIENTS
by: N. E. Gavrilova, et al.
Published: (2016-10-01)

Small dense low density lipoprotein has increased affinity for LDL receptor-independent cell surface binding sites: a potential mechanism for increased atherogenicity1
by: Narmer F. Galeano, et al.
Published: (1998-06-01)

The Molecular Interaction of Apolipoprotein A-I and Lecithin: Cholesterol Acyl Transferase
by: Cooke, Allison L., B.A.
Published: (2018)

Apolipoprotein J: A New Predictor and Therapeutic Target in Cardiovascular Disease?
by: Ning Yang, et al.
Published: (2015-01-01)

Echocardiography indicators in patients with atherosclerosis of peripheral arteries of the lower extremities dependent on T(–786)C polymorphism of the endothelial nitric oxide synthase gene promoter
by: V.I. Tseluyko, et al.
Published: (2018-03-01)

Terapia gênica de isquemia de membro é uma realidade?
by: Sang Won Han, et al.

Hyperlipoproteinemia(a) as a dangerous genetically determined violation of lipid metabolism and a risk factor for atherothrombosis and cardiovascular diseases
by: O. I. Afanasieva, et al.
Published: (2019-06-01)

Mechanistic insights into Lp(a)-induced IL-8 expression: a role for oxidized phospholipid modification of apo(a)
by: Corey A. Scipione, et al.
Published: (2015-12-01)

Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally[S]
by: Mohamad Navab, et al.
Published: (2011-06-01)

Paradoxical effects of SAA on lipoprotein oxidation suggest a new antioxidant function for SAA[S]
by: Shobini Jayaraman, et al.
Published: (2016-12-01)